Title of Collaborative Activity:
FDA Arthritis Drugs Advisory Committee Meeting
Description of Collaborative Activity:
An NIMH Program Officer was invited to serve as a voting ad hoc member of one of the FDA's standing advisory committees, which met to review a new drug application for the treatment of Chronic Fatigue Syndrome.
Type of Collaborative Activity:
Advisory Group
Year the Collaborative Activity Originated:
2012
NIH Participating Institutes/Centers/Office of the Director:
NIMH
HHS Agency Collaborators on this Activity:
CDC, FDA
